Totally implantable central venous access device in the treatment of patients with multi- and extensively drug-resistant tuberculosis co-infected with human immunodeficiency virus and with history of illicit drug use.
A. Skrahin (Minsk, Belarus), M. Makouski (Minsk, Belarus), D. Pechinsky (Minsk, Belarus), K. Dobysh (Minsk, Belarus), H. Hlushanina (Minsk, Belarus), A. Sinha (Minsk, Belarus), A. Skrahina (Minsk, Belarus)
Source: International Congress 2018 – Tuberculosis comorbidities
Session: Tuberculosis comorbidities
Session type: Thematic Poster
Disease area: Respiratory infections
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Related content which might interest you: